Happy Pride Month! 🌈 At Meridian, we celebrate the diversity of our global community and remain committed to fostering a culture where everyone feels seen, supported, and truly belongs. #PrideMonth #EveryoneBelongsHere #InclusionMatters #DiversityEquityInclusion #LGBTQIA #Belonging #LifeSciences #MeridianBioscience

ESHG 2026 starts tomorrow—and there’s still time to schedule a meeting with the Meridian team in Gothenburg. If you’re looking to simplify molecular assay development, reduce cold-chain dependency, or accelerate the path to commercialization, let’s connect at Booth 462. Meeting availability is limited as the conference approaches, so we encourage you to reserve time with our team today. Be sure to ask about our recently announced collaboration with #4bases and how we’re working together to advance ambient-stable solutions for molecular diagnostics and genomics applications. Featured at ESHG: 🧬 Liquid ambient-stable DNA qPCR master mixes 🧬 NEW lyophilized NGS enzymatic DNA fragmentation kit 🧬 Fully lyophilized NGS library preparation solutions Whether you’re developing molecular diagnostics, genetic testing assays, or next-generation sequencing workflows, our team is ready to discuss solutions tailored to your development goals. It's not too late, book now—we look forward to connecting with you in Gothenburg! hubs.la/Q04l5W6l0 Visit our event page: hubs.la/Q04l6L-T0 #ESHG2026 #HumanGenetics #Genomics #MolecularDiagnostics #NGS #qPCR #AssayDevelopment #GeneticResearch #Diagnostics #LifeScience #nextgensequencing #libraryprep @eshgsociety #biotech

Breaking News: Meridian Life Science and 4bases Collaborate to Advance Global NGS Accessibility We’re excited to announce a new collaboration between Meridian Life Science and 4bases SA to support the global deployment of KaryoSolver™, a next-generation cytogenetics assay designed for rapid structural variant analysis. By combining 4bases’ innovative assay platform with Meridian’s expertise in reagent stabilization, formulation science, and lyophilization of enzymatic reagents, this collaboration addresses a critical challenge in scaling NGS workflows worldwide: reagent stability. Together, we have helped enable key NGS library preparation components to be shipped and stored at ambient temperatures, reducing cold-chain dependency while supporting: ✅ Extended reagent shelf life ✅ Simplified inventory management ✅ More efficient global distribution ✅ Broader access to NGS technologies worldwide This collaboration demonstrates how assay innovation and advanced stabilization technologies can work together to support the future of scalable, globally deployable sequencing workflows. Read the press release: hubs.la/Q04l0Wqg0 To learn more, meet the 4Bases and Meridian teams at ESHG 2026 in Gothenburg, where we are both exhibiting and sharing the latest advances in genomic technologies. hubs.la/Q04l0PSx0 #NGS #NextGenSequencing #Genomics #MolecularDiagnostics #LifeScience #ReagentStabilization #Lyophilization #Cytogenetics #NewPartnership #PrecisionMedicine #Diagnostics #MeridianLifeScience #4bases @eshgsociety

Still relying on cold-chain qPCR workflows? Traditional qPCR mixes depend on refrigerated storage and shipping—raising costs, complicating logistics, and slowing scale-up. As workflows expand, this dependency is becoming harder to sustain. Our NEW Liquid Ambient-Stable DNA qPCR Mixes deliver true ambient stability for 12 months, maintaining performance in a liquid format with no need for lyophilization or air-drying. Choose the format that fits your development needs: 🔹 MDX360 – Liquid Stable Flex DNA qPCR Mix – Add primers/probes at the point of use for full customization; ideal for low–high throughput and assay optimization. 🔹 MDX364 – Liquid Stable Ready DNA qPCR Mix – A fixed, ready-to-run format with primers/probes added during manufacturing; engineered for scalable, repeatable production. Whether you’re building customizable workflows or fixed high-throughput assays, these mixes reduce cost and complexity—without compromising performance. Explore performance data/compare formats: hubs.la/Q04kB52f0 Contact a specialist/request a sample: hubs.la/Q04kDFHB0 #qPCRmastermixes #MolecularDiagnostics #AssayDevelopment #LifeSciences #PrecisionDiagnostics #NextGenDiagnostics #LiquidStableqPCR #AmbientStability #DiagnosticInnovation #ambientstableassay

Point-of-care diagnostics are transforming how and where testing happens—but challenges around enzyme stability, cost, and logistics can slow adoption. View our on-demand featured presentation "Empowering Molecular Point-of-Care Diagnostics with Ambient-Stable Chemistries" with William Ferreira, R&D Team Leader at Meridian Life Science. Explore how established and emerging molecular techniques—including qPCR, isothermal amplification, and NGS—can be adapted with ambient-stable reagent chemistries to enable faster, more scalable, and cost-effective testing at the point of care. Learn how Meridian’s technologies support: • Molecular point-of-care testing • Ambient-stable, cold-chain-free chemistries • Infectious disease diagnostics • Decentralized and near-patient testing • Rapid assay development in resource-limited settings ▶️ Watch now: hubs.la/Q04ksgrl0 Contact a specialist for more: hubs.la/Q04ks2010 #PointOfCareDiagnostics #MolecularDiagnostics #AmbientStable #ColdChainFree #DecentralizedTesting #InfectiousDisease #AssayDevelopment #LifeScienceInnovation #POCT #EnzymeStability

Meridian’s Lyo-Ready Genotyping Direct qPCR Master Mixes are engineered for ultra-sensitive SNP detection—supporting simplified direct workflows and high-confidence mutation analysis, even at very low copy numbers. Designed for commercial assay developers and molecular diagnostics manufacturers, these mixes deliver reliable performance in both liquid and lyophilized formats. Key advantages: ✅ Ultra-sensitive detection down to 1 copy using direct amplification ✅ High tolerance to common PCR inhibitors ✅ Tight fluorescence clustering for clear allele discrimination ✅ Available in liquid or lyophilized formats for extended shelf life and ambient transport Explore Meridian’s Lyo-Ready Genotyping Direct qPCR Mixes for blood, urine, stool and FFPE. View our product catalog: hubs.la/Q04kgksJ0 Contact a Specialist: hubs.la/Q04kgzNY0 #OncologyDiagnostics #LiquidBiopsy #SNPDetection #qPCR #MolecularDiagnostics #PrecisionOncology #IVD #AssayDevelopers #Lyophilization #genotyping #ambientstable

Get the Pack. Test the Difference. Seeing unexplained variability in your immunoassays? Interference could be the culprit. Try Meridian’s Antibody Interference Blocker Sample Pack and evaluate the impact on assay performance and data reliability—before committing. ☑️ Proven blockers for common immunoassay interferents ☑️ Targets HAMA, RF, and heterophilic antibodies ☑️ Works across ELISA, CLIA, and LFA platforms Choose from serum-based or animal-free options to match your workflow. Explore our blocker portfolio: hubs.la/Q04k7Dtf0 Get your sample pack today: hubs.la/Q04k7FdM0 #immunodiagnostics #antibodyblockers #assaydevelopment #HAMA #rheumatoidfactor #antibodyinterference #CLIA #ELISA #interferenceblockers #immunoassayblockers #HAMA #MouseIgG

Democratizing Access to NGS for Precision Oncology As next-generation sequencing expands beyond centralized labs, access, stability and simplicity are becoming essential to advancing precision oncology worldwide. Meridian is helping to lead this shift with ambient-stable, lyophilized library-preparation reagents designed to remove traditional barriers and enable broader adoption of NGS. What's the Impact? 🔹 Eliminates cold-chain dependence 🔹 Simplifies and streamlines workflows 🔹 Delivers consistent performance 🔹 Supports automation while reducing cost and environmental impact 🔹 Enables fast, reliable, cost-effective sequencing in resource-limited settings By stabilizing key steps across the library prep workflow, we are helping democratize NGS—empowering more labs to bring precision oncology to patients everywhere. Explore the data and download the poster to learn more. hubs.la/Q04jX-PD0 Visit our website: hubs.la/Q04jYglY0 #NGS #PrecisionOncology #Genomics #LifeSciences #MolecularDiagnostics #Biotech #nextgensequencing #LibraryPrep #eliminatecoldchain #pointofcare #ambientstablereagents

Sepsis remains a critical global health challenge where every hour counts. Traditional blood culture methods can be hampered by long turnaround times and inconsistent positivity rates — creating an urgent need for faster, more sensitive molecular approaches. Our clinical case study with PILOT GENE evaluates droplet digital PCR (ddPCR) for bloodstream infection detection, featuring Meridian’s Lyo-Ready qPCR Mix (MDX024) to support robust and reproducible assay performance. Key findings include: • Accelerated diagnostics with significantly reduced time to actionable results • Enhanced pathogen detection in clinical samples • Added insights into antimicrobial resistance • Consistent, reliable performance across formats and sample types when using Lyo-Ready qPCR MIx These results highlight the transformative potential of ddPCR-based workflows in sepsis diagnostics — and Meridian’s commitment to enabling clinical innovation with reliable molecular reagents. Download the full case study to explore the methodology, clinical insights, and implications for advancing sepsis diagnostics. hubs.la/Q04jKhFg0 #SepsisDiagnostics #ddPCR #MolecularDiagnostics #ClinicalInnovation #qPCR #InfectiousDisease #LyophilizedPCR #SepsisDetection #AssayDevelopers

Heading to ESHG 2026 in Gothenburg!? Stop by Booth #462 to discover how ambient-stable molecular solutions can help simplify assay development and support commercialization. From liquid ambient-stable qPCR master mixes to fully lyophilized NGS workflows, Meridian’s technologies are designed to help: ✔ Simplify laboratory workflows ✔ Reduce cold-chain storage and shipping requirements ✔ Support assay stability and reliability ✔ Accelerate the path from development to commercialization Featured at ESHG: 🧬 Liquid ambient-stable DNA qPCR master mixes 🧬 NEW lyophilized NGS enzymatic DNA fragmentation kit 🧬 Fully lyophilized NGS library preparation solutions Whether you’re developing molecular diagnostics, genetic testing assays, or next-generation sequencing workflows, our team is ready to discuss solutions tailored to your development goals. Visit Booth #462 | June 13–16 | Gothenburg, Sweden Schedule a meeting: hubs.la/Q04jyZzq0 Visit our event page: hubs.la/Q04jz2Qt0 #ESHG2026 #HumanGenetics #Genomics #MolecularDiagnostics #NGS #qPCR #AssayDevelopment #GeneticResearch #Diagnostics #LifeScience #nextgensequencing #libraryprep @eshgsociety

As warmer weather returns and mosquito activity increases across many regions, the need for accurate tropical and vector-borne disease testing remains a critical priority. Meridian Life Science helps diagnostic manufacturers develop reliable immunoassays for malaria, dengue, and Zika with high-quality antigens, antibodies, and blockers designed to support assay performance from development through deployment. Our portfolio includes: • Malaria targets including HRP-2, pLDH, aldolase, MSP1, and CSP • Dengue reagents for NS1, IgM, and IgG assay development • Zika solutions, including ZEROX-REACT™ ZIKA Envelope Antigen, engineered to minimize cross-reactivity with other flaviviruses Whether developing laboratory-based or point-of-care assays, our reagents help support sensitive, specific, and reliable test development for global health applications. Learn more: hubs.la/Q04jmMKx0 Contact a specialist: hubs.la/Q04jmM930 #GlobalHealth #AssayDevelopment #ImmunoDiagnostics #DiagnosticDevelopment #TropicalDiseases #VectorBorneDiseases #Malaria #Dengue #Zika #LifeScience #pointofcare #immunoassays

Cold-chain requirements can create real challenges for diagnostic assay developers — from frozen shipments and limited storage space to increased waste and workflow disruption. Meridian’s Liquid Ambient-Stable DNA qPCR Mixes are designed to help reduce that pressure with 12-month ambient stability in a liquid format, without converting assays to a dry state. Choose the format that fits your workflow: MDX360 Liquid Stable Flex DNA qPCR Mix: For teams that need flexibility to add primers and probes at the point of use. MDX364 Liquid Stable Ready DNA qPCR Mix: For developers and manufacturers looking for a more ready-to-run liquid qPCR format. One technology. Two purpose-built formats. More flexibility for development, manufacturing, and point-of-care applications. Explore the data and compare formats: hubs.la/Q04j2FmN0 Contact a Specialist: hubs.la/Q04j2Xcb0 #qPCR #AmbientStable #ReduceColdChain #MolecularDiagnostics #DiagnosticsDevelopment #AssayDevelopment #LifeScience #MolecularReagents #PointOfCareTesting

Is your workflow struggling with clean amplification, balanced coverage, and downstream sequencing accuracy? In a recent customer evaluation, our MDX122 qPCR mix was put to the test in a 177-plex amplicon tNGS assay—and delivered performance equivalent to their commercial kit. Find out how our MDX122 performed across: • Amplification balance • GC-rich targets • Primer-dimer tendency • Uniformity • Downstream accuracy Get the data in our new application note "Inside an Assay Developer’s Study – qPCR for tNGS" hubs.la/Q04j36TT0 Curious how the right qPCR chemistry can strengthen your results?hubs.la/Q04j362p0 #qPCR #targetedNGS #MolecularDiagnostics #AssayDevelopers #PCROptimization #NGSChemistry #ApplicationNote #Genomics #MultiplexPCR #nextgensequencing #tNGS

Are you still battling inconsistent results in your immunoassays? Interference from HAMA, RF, and other heterophilic antibodies can skew data accuracy—especially in post-COVID samples. In this white paper, Meridian introduces TRU Block™, a next-generation universal blocker that delivers stronger, broader protection than traditional agents like Mouse IgG: ✅ Broad coverage against HA, HAMA, and RF ✅ High-affinity binding even at lower concentrations ✅ Proven performance across ELISA, CLIA, and lateral flow assays Enhance assay reliability and reduce costs on retesting Download the white paper: hubs.la/Q04hS-v60 Explore our portfolio of blockers: hubs.la/Q04hSH5T0 Speak to a specialist to request a sample: hubs.la/Q04hT8Dg0 #Immunoassays #AssayDevelopment #TRUBlock #ImmunoDiagnostics #ELISA #LifeScienceDiagnostics #ClinicalLaboratory #HAMA #IVD #LateralFlow #CLIA

For today’s diagnostic assays, animal-free blockers raise the bar even further. They deliver consistently low background, superior lot-to-lot reproducibility, and a defined, ethical alternative to serum-derived materials. That consistency makes them especially well-suited for automated, high-throughput, and globally scaled platforms. Assay interference can quietly undermine immunoassay performance—leading to false positives, unstable signals, and reduced confidence in results. High-quality immunoassay blockers are essential for maintaining assay integrity. They help minimize non-specific binding and reduce interference from HAMA, rheumatoid factor (RF), and heterophilic antibodies—protecting both sensitivity and specificity. Explore our portfolio of high-performance immunoassay blockers: ➡️ Animal-Free HAMA Blockers – Low background, defined composition ➡️ K-BLOCK™ / Mouse-FREE IgG – High-performance, animal-free universal blockers ➡️ TRU Block™ ULTRA, TRU Block™, TRU Block™ 3 – Proven protection against common assay interference ➡️ Mouse IgG – HAMA Blocker – Targeted protection for mouse monoclonal-based assays Consistent blockers. Cleaner data. Greater confidence. Learn more: hubs.la/Q04hFbRp0 Request a sample: hubs.la/Q04hDYKD0 #ImmunoassayBlockers #AssayOptimization #ImmunoDiagnostics #IVDDevelopment #AssayInterference #LifeSciences #Biotech #IgGBlocker #MouseFreeBlocker #MouseFreeReagents

Liquid biopsy is transitioning from a research-driven concept to clinically actionable tools and that shift is starting to have real impact. Advances in next-generation sequencing, molecular detection sensitivity and data analytics are now enabling the identification of genomic alterations that were previously undetectable. This has resulted in earlier insights, more precise stratification and improved monitoring opportunities in oncology workflows. Liquid biopsy is transitioning from a research-driven concept to clinically actionable tools and that shift is starting to have a real impact. academia, diagnostics, pharma and regulatory bodies came together to address critical challenges like validation, reproducibility and standardization. Here’s what’s shaping the future of liquid biopsy: 🔹 The shift from discovery to clinical implementation 🔹 Expansion beyond blood into other biofluids 🔹 The growing role of AI and advanced data analysis 🔹 Increased collaboration across the industry 🔹 Heightened demand for highly sensitive and reproducible assays As the field advances, ensuring consistent, reliable performance will be essential to unlocking the full potential of liquid biopsy in precision oncology. Read the full blog to get more insight: hubs.la/Q04hw6P-0 #LiquidBiopsy #CancerDiagnostics #PrecisionOncology #MolecularDiagnostics #Genomics #NextGenSequencing #BiotechInnovation #AIDiagnostics #LifeSciences #cancerbiomarkers #pointofcare

Meridian is heading to ESHG 2026 in Gothenburg! We’re excited to exhibit at the European Society of Human Genetics (June 13-16) and invite you to visit us at Booth #462 to explore solutions designed to simplify and accelerate molecular assay development and commercialization. At the conference, we’ll be showcasing: 🧬 Liquid ambient-stable DNA qPCR master mixes 🧬 Our newly launched lyophilized NGS enzymatic DNA fragmentation kit 🧬 Fully lyophilized NGS library preparation solutions Our ambient-stable technologies are engineered to help improve assay stability and reliability, maintain high sensitivity, simplify workflows and reduce cold-chain dependency. By supporting faster development timelines and a smoother transition from R&D to commercialization, these innovations help enable broader access to next-generation diagnostics. Schedule a meeting with our team or stop by Booth #462 to learn how Meridian can help streamline workflows, reduce operational complexity and support faster innovation in molecular diagnostics and genetic research. We look forward to seeing you in Gothenburg! Schedule a meeting: hubs.la/Q04h81VJ0 Visit our Event Page: hubs.la/Q04h7Y390 #ESHG2026 #HumanGenetics #Genomics #MolecularDiagnostics #NGS #qPCR #AssayDevelopment #GeneticResearch #Diagnostics #LifeScience #nextgensequencing #libraryprep @eshgsociety

What if qPCR reagents no longer needed to depend on the cold chain? Cold-chain requirements can add cost, complexity, and risk to molecular assay development and distribution. Meridian’s Liquid Ambient-Stable qPCR Mixes help address these challenges with ready-to-use liquid reagents engineered for ambient temperature stability. These liquid-format qPCR mixes are designed to simplify workflows, reduce logistics challenges, and support more scalable molecular testing without compromising performance. Key advantages include: ✅ 12 months of ambient temperature stability ✅ Reduced reliance on cold-chain shipping and storage ✅ Easier handling with ready-to-use liquid formats ✅ Flexible options for decentralized testing and high-throughput labs ✅ Greater support for sustainable and reliable assay development As molecular diagnostics continue to expand globally, removing cold-chain barriers can help improve accessibility, efficiency, and resilience across the testing landscape. Watch the video to see how Meridian’s Liquid Ambient-Stable qPCR Mixes are helping transform assay development: hubs.ly/Q04h7Sdw0 Learn more | Contact a Specialist hubs.ly/Q04h8hs90 #qPCR #Diagnostics #MolecularDiagnostics #LifeSciences #ColdChainFree #AssayDevelopment #AmbientStableReagents #qPCR #LiquidqPCRmixes

The future of STI testing is being shaped by speed, access, and innovation. As STI rates continue to challenge public health systems worldwide, diagnostic developers are looking for solutions that can support earlier detection, broader access, and more flexible testing models. Meridian’s GEN-sponsored eBook takes a closer look at how molecular diagnostics and immunoassays are helping move STI testing beyond traditional lab settings and into clinics, community programs, point-of-care environments, and at-home collection models. Inside the eBook, explore: 🔹 How STI testing technologies have evolved over time 🔹 Why point-of-care, self-collection, and at-home testing are gaining momentum 🔹 Emerging trends such as multiplexing, ambient-stable reagents, and digital connectivity 🔹 Lessons from four decades of progress in HIV diagnostics As testing becomes more accessible and adaptable, these innovations are helping reduce barriers, support earlier intervention, and improve public health outcomes. Download the free eBook: hubs.la/Q04g-5ZS0 Learn more about our STI Assays: hubs.la/Q04g-Ndx0 #STIDiagnostics #STDtesting #STDprevention #MolecularDiagnostics #Immunoassays #STI #PublicHealth #LifeSciences #PointOfCare #HealthcareInnovation @GENbio

As our Women’s Health Week series comes to a close, we’re highlighting the importance of cervical cancer screening and the role oncoviruses can play in cancer development. Viruses such as HPV, HBV, HCV, EBV and HTLV-1 are associated with cancer progression, and co-infections may further intensify their effects. In cervical cancer, HPV detection remains especially important as screening strategies continue to evolve. According to the American Cancer Society, cervical cancer is most frequently diagnosed in women ages 35 to 64, and cases are rarely seen in women who have received regular screening before age 65. As traditional Pap smears are increasingly complemented or replaced by HPV DNA tests, PCR-based assays offer sensitive detection of multiple HPV types and may support expanded access through patient self-collection-compatible formats. Meridian supports viral oncology research and multiplex assay development with high-performance antigens, antibodies and molecular reagents for sensitive, scalable detection. Meridian’s Lyo-Ready Genotyping Direct qPCR Urine Mix is designed to support fast, precise and reproducible allelic discrimination from urine samples, helping assay developers advance urine-based genotyping workflows. Learn more about viral co-infections and cancer progression: hubs.la/Q04gNMTw0 Explore Meridian’s Lyo-Ready Genotyping Direct qPCR Urine Mix: hubs.la/Q04gNJcN0 #WomensHealthWeek #WomensHealth #EndHPV #CancerPrevention #ViralOncology #LiquidBiopsy #STIdiagostics #DetectOncoviruses #CervicalCancerDetection #NWHW